Hepatotoxicity associated with the use of Herbalife Lifrarskaði tengdur notkun á Herbalife

: Many herbal products are known to be hepatotoxic. In a recent survey in Iceland concerning adverse reactions related to herbal medicines, Herbalife products were implicated in the majority of the reported cases of hepatotoxicity.





Methods: The clinical presentations of five cases of Herbalife related liver injury during the period of 1999-2008 are analysed. Causality was assessed by using the WHO-UMC system for causality assessment and the RUCAM method.

Results: Of the five cases there were four females and one male; median age was 46 years (range 29-78). Herbalife had been used for 1 to 7 months prior to presentation. Four patients presented with a hepatocellular and one with a cholestatic reaction. Median values were for bilirubin 190 mmol/L (range: 26-311; ref. < 20 mmol/L), ALP 407 U/L (range: 149-712; ref. 35-105 U/L) and ALT 24 87 U/L (range: 456-2637; ref. 70 and 45 U/L for males and females, respectively). Liver biopsy was performed in 2 patients and was consistent with toxic hepatitis in both cases. Other causes of hepatitis were excluded by appropriate serological testing and ultrasound. Causality assessment according to RUCAM was probable in three cases and possible in two. Using the WHO-UMC criteria causality was certain in one case, probable in two and possible in two cases.

Conclusions: Hepatotoxicity is probably associated with the use of Herbalife products. Hepatotoxicity due to herbal remedies is an important differential diagnosis in the diagnostic work-up of liver injury.





Table I

The table shows Herbalife products consumed by the patients. The list is not exhaustive

Product name case 1 2 3 4 5 Rose Ox x x x x x Florafibre x x Thermojetics x x x Fiber- och örttabletter x x Herbalifeline x Tang Kuei x x

Table II

Information on the patients, diagnosis and causality according to the WHO and RUCAM criteria

pat. no. sex age (years) latency (months) type of liver injury biopsy rechallenge causality (WHO) causality (RUCAM) 1 F 46 1 HC yes not done probable probable 2 F 47 ? HC no not done possible possible 3 F 29 4 HC yes not done possible possible 4 5 F M 44 78 4-5 4-5 chol chol no no positive not done certain probable probable

probable

HC = hepatocellular damage

chol = cholestatic hepatitis

latency = duration of Herbalife consumption

rechallenge = cf. WHO criteria of causality

Table III

Table shows highest values for each patient (times upper normal limit).

pat. no. sex bilirubin ref. <20 mmol/L ALP ref. 35-105 U/L ALT ref. <70 for M, <45 for F, U/L 1 F 311 (15.6) 149 (1.4) 1134 (25.2) 2 F 190 (9.5) 407 (3.9) 2600 (57.8) 3 F 247 (12.3) 547 (5.2) 2487 (55.3) 4 5 F M 64 (3.2) 26 (1.3) 231 (2.2) 712 (6.8) 2637 (58.6) 456 (6.5)

ALP=alkaline phosphatase

ALT=alanine aminotransferase